Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.
about
Anti-CD138-targeted interferon is a potent therapeutic against multiple myeloma.The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cellsPrimary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.Molecular genetic studies of gene identification for osteoporosis: the 2009 updateIRF4: Immunity. Malignancy! Therapy?Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines.A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells.Apoptotic induction in B-cell acute lymphoblastic leukemia cell lines treated with a protein kinase Cβ inhibitor.Oxidative Stress: Harms and Benefits for Human Health
P2860
Q35321868-49637702-3374-458B-9071-2900AFE1FFB4Q35607281-73AD3C2E-79DE-4A1C-9A2C-FEBC0BFBBAB7Q35634280-FC6B7F36-71F6-46B1-8E5B-0EF2836C1B70Q35834665-EF52CD55-5C53-42B7-AD1A-ECA7F57AA182Q36003387-BDEA124C-2243-43E4-93C1-8C33FD927C5DQ37454043-688659FC-C3A4-4C34-A54C-74CCC09F9927Q38221107-E5DB63DE-8BAD-4445-869E-8ABF6AFAA581Q38940707-8D343DBB-D41F-4D28-AC42-567DB630C42BQ39550137-78E1DC20-0AE5-4DA8-BECE-5284392CBCFEQ39601989-1CEF3312-E942-492F-8C86-EB8223012177Q41341951-4FAF928B-BE38-4A3A-BAE5-8AC6778AC6A0
P2860
Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Molecular targeting of the PKC ...... on of MYC and IRF4 expression.
@en
Molecular targeting of the PKC-beta inhibitor enzastaurin
@nl
type
label
Molecular targeting of the PKC ...... on of MYC and IRF4 expression.
@en
Molecular targeting of the PKC-beta inhibitor enzastaurin
@nl
prefLabel
Molecular targeting of the PKC ...... on of MYC and IRF4 expression.
@en
Molecular targeting of the PKC-beta inhibitor enzastaurin
@nl
P2093
P50
P356
P1476
Molecular targeting of the PKC ...... on of MYC and IRF4 expression.
@en
P2093
Daniela Intini
Donata Verdelli
Giorgio Lambertenghi Deliliers
Luigia Lombardi
Maria Cosenza
Monica Civallero
P2860
P356
10.1002/HON.875
P577
2009-03-01T00:00:00Z